Tranont Adds Metabolic Health Expert Dr. Erin Glynn to Advisory Board
Tranont Adds Metabolic Health Expert Dr. Erin Glynn to Advisory Board In a bold move that underscores its continued investment in science-driven wellness and product development, Tranont, a company known…
Glaukos Reports Financial Results for First Quarter 2025
Glaukos Reports Financial Results for First Quarter 2025 Glaukos Corporation , a global ophthalmic pharmaceutical and medical technology innovator, delivered a powerful performance in the first quarter of 2025, signaling…
Henry Meds Launches Personalized Hormone Therapies for Menopause Relief
Henry Meds Launches Personalized Hormone Therapies for Menopause Relief Henry Meds, a fast-growing innovator in the telehealth sector, announced a major expansion of its healthcare offerings today with the launch…
Pilatus Biosciences Unveils Preclinical Data on CD36 Antibody PLT012 for Liver Cancer
Pilatus Biosciences Unveils Preclinical Data on CD36 Antibody PLT012 for Liver Cancer Pilatus Biosciences, a biotechnology company dedicated to developing next-generation immunometabolic therapies for cancer, has announced the publication of…
Revelation Biosciences Advances Development of Gemini Therapy for Infections in Severe Burn Patients
Revelation Biosciences Advances Development of Gemini Therapy for Infections in Severe Burn Patients Revelation Biosciences, Inc. a clinical-stage life sciences company pioneering approaches to rebalancing inflammation to optimize human health,…
FUJIFILM Cellular Dynamics Names Delara Motlagh as Chief Operating Officer
FUJIFILM Cellular Dynamics Names Delara Motlagh as Chief Operating Officer In a strategic move to enhance its operational leadership and accelerate the growth of its cutting-edge platforms in induced pluripotent…
Creyon Bio and Eli Lilly Forge Partnership to Develop RNA-Targeted Oligonucleotide Therapies
Creyon Bio and Eli Lilly Forge Partnership to Develop RNA-Targeted Oligonucleotide Therapies Creyon Bio, Inc., a leader in innovative RNA-targeted therapies, has announced a transformative global licensing and multi-target research…
Xencor Reports Positive Early Data for Anti-TL1A Antibody in Bowel Disease
Xencor Reports Positive Early Data for Anti-TL1A Antibody in Bowel Disease Xencor, Inc. a leading clinical-stage biopharmaceutical company specializing in the development of engineered antibodies for the treatment of cancer…
Sage Therapeutics Reports Q1 2025 Results and Pipeline Highlights
Sage Therapeutics Reports Q1 2025 Results and Pipeline Highlights Sage Therapeutics, Inc., a biopharmaceutical company committed to advancing brain health, released its financial results and operational highlights for the first…
QIAGEN Enhances Digital PCR Lineup With New Lentivirus Tools for Cell and Gene Therapy QC
QIAGEN Enhances Digital PCR Lineup With New Lentivirus Tools for Cell and Gene Therapy QC In a move that further cements its position as a key player in the evolving…
Guardant Health Showcases Strong Shield Test Results Across 10 Cancer Types
Guardant Health Showcases Strong Shield Test Results Across 10 Cancer Types At the 2025 Annual Meeting of the American Association for Cancer Research (AACR), Guardant Health, Inc. , a leader…
Claritas Rx Unveils Groundbreaking Care Coordination Platform for Specialty and Rare Disease Patients
Claritas Rx Unveils Groundbreaking Care Coordination Platform for Specialty and Rare Disease Patients In an era where healthcare delivery is increasingly fragmented, and specialty and rare disease patients often navigate…